Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Oct 18 2023

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE · · 3 pages · English

On 6ix: 6ix.com/news/press-release-oct-18-2023-9

Watch Glenmark Pharmaceuticals' latest callGlenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call · Replay · Nov 6Read the transcript of Glenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call

Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 18, 2023, titled "Glenmark Pharma is first to launch a Triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 Diabetes in Adults with Co-morbidities".

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases